Europe

January 23, 2019January 31, 2019

Orkambi Approved in Europe for Younger CF Patients with F508del Mutations

cystic fibrosis, News

The European Commission has approved the label extension of Orkambi (lumacaftor/ivacaftor) for the treatment of children ages 2-5 with cystic fibrosis (CF) due to F508del mutations, Vertex Pharmaceuticals, the ... Read more

November 19, 2018November 19, 2018

Orkambi Closer to Being Approved in Europe to Treat Children Ages 2-5 With Cystic Fibrosis

cystic fibrosis, News

The European Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Orkambi (lumacaftor/ivacaftor) as a treatment for children ages 2-5 with cystic fibrosis (CF) due to F508del mutations, ... Read more

May 18, 2018May 19, 2018

#ECFS2018 – Disparities in CF Care Across Europe Focus of ECFS Meeting in Belgrade

cystic fibrosis, News

A baby born with cystic fibrosis (CF) in Germany today is likely to live to be 40 or 50, while another born in the Ukraine will probably die before ... Read more

August 14, 2017August 14, 2017

CF Patients in Europe Wanted for Phase 2 Trial of Investigational Therapy RPL554

cystic fibrosis, News

Verona Pharma recently announced the company’s accomplishments in the last six months, including an update to the company’s clinical trial in cystic fibrosis (CF) and positive interim results for its investigational ... Read more

July 21, 2017July 21, 2017

Boomer Esiason Foundation Taking Its Bike to Breathe CF Awareness Effort to Europe

cystic fibrosis, News

In September 2016, Jerry Cahill and Emily Schaller joined a high-profile effort to persuade cystic fibrosis patients like themselves to cycle to improve their health. The title of the ... Read more

April 5, 2017April 5, 2017

ProQR’s Cystic Fibrosis Therapy QR-010 Now Protected by U.S., European Patents Until 2033

cystic fibrosis, News

Dutch pharmaceutical company ProQR Therapeutics now has two key patents protecting its first-in-class ribonucleic acid (RNA)-based oligonucleotide QR-010 for the treatment of cystic fibrosis (CF) in the United States and Europe. The patents ... Read more

November 10, 2016November 28, 2016

Vertex to Request Approval of Orkambi as CF Therapy for Young Children in EU

News

Children with cystic fibrosis (CF) who carry the F508del mutation in both CFTR gene copies showed improved lung function after treatment with Orkambi (ivacaftor/lumacaftor), according to results in a ... Read more

October 6, 2016October 6, 2016

Researchers Are Developing Mobile App to Help Manage, Monitor CF Patients

News

A team of 12 research partners in seven European countries are engaged in a project to develop a mobile app designed to promote autonomy and help people with cystic fibrosis (CF), ... Read more

April 13, 2016April 13, 2016

Raptor Announces the First European Sales of Quinsair, a CF Inhalation Therapy

News

Raptor Pharmaceutical Corp. announced that the first commercial sales of Quinsair (levofloxacin inhalation solution), a treatment for adults with cystic fibrosis, have been made in Denmark and Germany. Quinsair is an antibiotic ... Read more

Pin It on Pinterest